Structured care for patients after acute myocardial infarction: Sudden cardiac death prevention - Data from the Leiden MISSION! AMI study

Europace

Volumn 12, Issue 3, 2010, Pages 378-384

  Atary, Jael Z ^a   Borleffs, C Jan Willem ^a   Liem, Su San ^a   Bax, Jeroen J ^a   Van Der Hoeven, Bas L ^a   Bootsma, Marianne ^a   Van Der Wall, Ernst E ^a   Van Erven, Lieselot ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute myocardial infarction; Implantable cardioverter defibrillator; Sudden cardiac death

Indexed keywords

TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ALGORITHM; ARTICLE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFUSION; HUMAN; IMPLANTATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; SUDDEN DEATH;

AGED; AMBULATORY CARE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EMERGENCY MEDICAL SERVICES; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TROPONIN T; VENTRICULAR FUNCTION, LEFT;

EID: 77749323312     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup420     Document Type: Article

References (30)

1. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992;85:I2-10.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
5. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in Collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:2820-40.
6. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006;27:2099-140.
7. Liem SS, van der Hoeven BL, Oemrawsingh PV, Bax JJ, van der Bom JG, Bosch J et al. MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction. Am Heart J 2007;153:14-1.
8. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:e82-292.
9. De BG, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10.
10. Van de WF, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
11. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
12. Ioannidis JP, Trikalinos TA, Danias PG. Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J Am Coll Cardiol 2002;39:2059-68.
13. van der Burg AE, Bax JJ, Boersma E, Pauwels EK, van der Wall EE, Schalij MJ. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 2003;108:1954-9.
14. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348: 771-5.
15. De LG, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004;109:1223-5.
16. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004;109:745-9.
17. Schiele F, Meneveau N, Seronde MF, Caulfield F, Fouche R, Lassabe G et al. Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart J 2005;26:873-80.
18. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008;359:2245-53.
19. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309: 331-6.
20. Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF et al. Myocardial infarction patients in the 1990s - their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996;27:1119-27.
21. Morishima I, Sone T, Tsuboi H, Mukawa H, Uesugi M, Morikawa S et al. Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging. J Nucl Cardiol 2008;15: 631-7.
22. Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW et al. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007;153:1089-94.
23. Hlatky MA, Mark DB. The high cost of implantable defibrillators. Eur Heart J 2007;28:388-91.
24. Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med 2005;142:593- 600.
25. Barold HS. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval? Card Electrophysiol Rev 2003;7:443-6.
26. Essebag V, Eisenberg MJ. Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness. Card Electrophysiol Rev 2003;7: 43-8.
27. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5.
28. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation 2008;117:1918-26.
29. sheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NA III, Link MS. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2008;19:784-9.
30. Goldenberg I. Long-Term Outcome after Implantation of Cardioverter Defibrillator: An Eight Year Follow-Up Study of the Multicenter Automatic Defibrillator Trial II. Abstract Presented at Heart Rhythm 2009 Scientific Sessions, Boston, MA, USA, 14, May, 2009.